ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $11,000 | -65.6% | 22,900 | +4.6% | 0.00% | – |
| Q2 2021 | $32,000 | -45.8% | 21,900 | -40.7% | 0.00% | – |
| Q1 2021 | $59,000 | +118.5% | 36,900 | +70.2% | 0.00% | – |
| Q1 2020 | $27,000 | -64.9% | 21,683 | -40.8% | 0.00% | – |
| Q4 2019 | $77,000 | +120.0% | 36,600 | +130.2% | 0.00% | – |
| Q3 2019 | $35,000 | -71.8% | 15,900 | -67.6% | 0.00% | – |
| Q2 2019 | $124,000 | -37.4% | 49,000 | -14.2% | 0.00% | – |
| Q1 2019 | $198,000 | -58.1% | 57,100 | -53.5% | 0.00% | – |
| Q3 2018 | $473,000 | +188.4% | 122,708 | +51.5% | 0.00% | – |
| Q4 2017 | $164,000 | -73.9% | 80,986 | -40.7% | 0.00% | -100.0% |
| Q3 2017 | $628,000 | +450.9% | 136,627 | +159.3% | 0.00% | – |
| Q2 2017 | $114,000 | +1.8% | 52,700 | +45.6% | 0.00% | – |
| Q1 2017 | $112,000 | +72.3% | 36,200 | +44.2% | 0.00% | – |
| Q4 2016 | $65,000 | -46.3% | 25,100 | -22.9% | 0.00% | – |
| Q3 2016 | $121,000 | – | 32,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $21,040,000 | 1.36% |
| Palo Alto Investors LP | 1,634,608 | $6,359,000 | 0.37% |
| WealthTrust Axiom LLC | 200,000 | $778,000 | 0.29% |
| Granahan Investment Management | 1,455,676 | $5,663,000 | 0.18% |
| SHEPHERD KAPLAN KROCHUK, LLC | 127,846 | $497,000 | 0.10% |
| Joel Isaacson & Co., LLC | 80,660 | $314,000 | 0.06% |
| Cornerstone Capital, Inc. | 39,700 | $154,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 281,650 | $1,096,000 | 0.02% |
| Advisor Group, Inc. | 131,992 | $513,000 | 0.01% |
| INTEGRATED WEALTH COUNSEL, LLC | 1,000 | $4,000 | 0.01% |